The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(1-(4-methylbenzyl)indolin-5-yl)-3-(pyridin-4-ylmethyl)urea ID: ALA4878914
PubChem CID: 164627527
Max Phase: Preclinical
Molecular Formula: C23H24N4O
Molecular Weight: 372.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(CN2CCc3cc(NC(=O)NCc4ccncc4)ccc32)cc1
Standard InChI: InChI=1S/C23H24N4O/c1-17-2-4-19(5-3-17)16-27-13-10-20-14-21(6-7-22(20)27)26-23(28)25-15-18-8-11-24-12-9-18/h2-9,11-12,14H,10,13,15-16H2,1H3,(H2,25,26,28)
Standard InChI Key: KXOLQGUPBUNOAD-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
7.0275 -10.2747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0264 -11.1020 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7412 -11.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4576 -11.1016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4547 -10.2710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7393 -9.8619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1676 -9.8558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8837 -10.2657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5965 -9.8505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3126 -10.2602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5934 -9.0255 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0254 -9.8451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7374 -10.2567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7261 -8.6067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0166 -9.0236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4471 -9.0163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4506 -9.8420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2369 -10.0938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7194 -9.4237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2313 -8.7580 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4829 -7.9722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2891 -7.7973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8397 -8.4109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6453 -8.2364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8976 -7.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3381 -6.8379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5347 -7.0155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7036 -7.2741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 13 2 0
13 17 1 0
16 14 1 0
14 15 2 0
15 12 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
25 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.47Molecular Weight (Monoisotopic): 372.1950AlogP: 4.27#Rotatable Bonds: 5Polar Surface Area: 57.26Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.02CX LogP: 3.99CX LogD: 3.99Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.70Np Likeness Score: -1.90
References 1. Akiu M, Tsuji T, Sogawa Y, Terayama K, Yokoyama M, Tanaka J, Asano D, Sakurai K, Sergienko E, Sessions EH, Gardell SJ, Pinkerton AB, Nakamura T.. (2021) Discovery of 1-[2-(1-methyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-3-(pyridin-4-ylmethyl)urea as a potent NAMPT (nicotinamide phosphoribosyltransferase) activator with attenuated CYP inhibition., 43 [PMID:33887438 ] [10.1016/j.bmcl.2021.128048 ]